Infralimbic D1 receptor agonist effects on spontaneous novelty exploration and anxiety-like defensive responding in CD-1 mice

Behavioural Brain Research

Volumn 152, Issue 1, 2004, Pages 67-79

  Wall, P M ^a,b   Blanchard, R J ^a,b   Markham, C ^b   Yang, M ^b   Blanchard, D C ^a,c  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

SAP; AAR; alternate arm return ratio; D1; D2; DA; dopamine; dopamine D1 receptors; dopamine D2 receptors; IL; infralimbic vmPFC; OE; open arm entries; OTR; percent spontaneous alternation performance; same arm return ratio; SAR; ventromedial prefrontal cortex; vmPFC

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT;

ANALYTIC METHOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BODY POSTURE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG INFUSION; DRUG SCREENING; EXPLORATORY BEHAVIOR; HEAD MOVEMENT; LIMBIC SYSTEM; MALE; MAZE TEST; MOUSE; MOUSE STRAIN; NONHUMAN; PREDATOR; PRIORITY JOURNAL; RISK ASSESSMENT; TASK PERFORMANCE; TIME;

AGGRESSION; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BENZAZEPINES; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; LIMBIC SYSTEM; MALE; MAZE LEARNING; MICE; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D1;

EID: 2342473803     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2003.09.035     Document Type: Article

References (108)

1. Andersen P.H., Jansen J.A. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. Eur. J. Pharmacol. 188:1990;335-347
2. Andersen S.L., Teicher M.H. Serotonin laterality in amygdala predicts performance in the elevated plus maze in rats. Neuroreport. 10:1999;3497-3500
3. Anisman H., Kelly O., Hayley S., Borowski T., Merali Z., McIntyre D.C. Acoustic startle and fear-potentiated startle in rats selectively bred for fast and slow kindling rates: relation to monoamine activity. Eur. J. Neurosci. 12:2000;4405-4416
4. Arnsten A.F. Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms. Prog. Brain Res. 126:2000;183-192
5. Bassareo V., De Luca M.A., Di Chiara G. Differential expression of motivational stimulus properties by dopamine in nucleus accumbens shell versus core and prefrontal cortex. J. Neurosci. 22:2002;4709-4719
6. Bast T., Pezze M.A., Feldon J. Dopamine receptor blockade in the rat medial prefrontal cortex reduces spontaneous and amphetamine-induced activity and does not affect prepulse inhibition. Behav. Pharmacol. 13:2002;669-673
7. Blanchard DC, Blanchard RJ, Rodgers RJ. Risk assessment and animal models of anxiety. Basel: Birkhauser Verlag AG; 1991. p. 117-34.
8. Blanchard D.C., Griebel G., Blanchard R.J. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci. Biobehav. Rev. 25:2001;205-218
9. Blanchard D.C., Griebel G., Blanchard R.J. The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic. Eur. J. Pharmacol. 463:2003;97-116
10. Blanchard R.J., Blanchard D.C., Rodgers J., Weiss S.M. The characterization and modelling of antipredator defensive behavior. Neurosci. Biobehav. Rev. 14:1990;463-472
11. Broersen L.M., Heinsbroek R.P., de Bruin J.P., Laan J.B., Joosten R.N., Olivier B. Local pharmacological manipulations of prefrontal dopamine affect conflict behaviour in rats. Behav. Pharmacol. 6:1995;395-404
12. Broersen L.M., Heinsbroek R.P., de Bruin J.P., Olivier B. Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition. Biol. Psychiatry. 40:1996;1083-1090
13. Cabib S., D'Amato F.R., Puglisi-Allegra S., Maestripieri D. Behavioral and mesocorticolimbic dopamine responses to non aggressive social interactions depend on previous social experiences and on the opponent's sex. Behav. Brain Res. 112:2000;13-22
14. Cartmell J., Perry K.W., Salhoff C.R., Monn J.A., Schoepp D.D. Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade. Neuropharmacology. 40:2001;847-855
15. Cartmell J., Salhoff C.R., Perry K.W., Monn J.A., Schoepp D.D. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum. Brain Res. 887:2000;378-384
16. Chefer V.I., Moron J.A., Hope B., Rea W., Shippenberg T.S. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine. Neuroscience. 101:2000;619-627
17. Cole J.C., Rodgers R.J. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology (Berl). 114:1994;288-296
18. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-176
19. Doherty M.D., Gratton A. Effects of medial prefrontal cortical injections of GABA receptor agonists and antagonists on the local and nucleus accumbens dopamine responses to stress. Synapse. 32:1999;288-300
20. Druzin M.Y., Kurzina N.P., Malinina E.P., Kozlov A.P. The effects of local application of D2 selective dopaminergic drugs into the medial prefrontal cortex of rats in a delayed spatial choice task. Behav. Brain Res. 109:2000;99-111
21. Espejo E.F. Selective dopamine depletion within the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze. Brain Res. 762:1997;281-284
22. Falzone T.L., Gelman D.M., Young J.I., Grandy D.K., Low M.J., Rubinstein M. Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear. Eur. J. Neurosci. 15:2002;158-164
23. Feenstra M.G., Botterblom M.H., van Uum J.F. Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: inhibition by diazepam. Neurosci. Lett. 189:1995;81-84
24. Feenstra M.G., Botterblom M.H., van Uum J.F. Behavioral arousal and increased dopamine efflux after blockade of NMDA-receptors in the prefrontal cortex are dependent on activation of glutamatergic neurotransmission. Neuropharmacology. 42:2002;752-763
25. Fernandes C., File S.E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol. Biochem. Behav. 54:1996;31-40
26. Fernandez Espejo E. Prefrontocortical dopamine loss in rats delays long-term extinction of contextual conditioned fear, and reduces social interaction without affecting short-term social interaction memory. Neuropsychopharmacology. 28:2003;490-498
27. Fride E., Weinstock M. Prenatal stress increases anxiety related behavior and alters cerebral lateralization of dopamine activity. Life Sci. 42:1988;1059-1065
28. George T.P., Picciotto M.R., Verrico C.D., Roth R.H. Effects of nicotine pretreatment on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects. Biol. Psychiatry. 49:2001;300-306
29. George T.P., Verrico C.D., Roth R.H. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress. Brain Res. 801:1998;36-49
30. Giorgi O., Lecca D., Piras G., Driscoll P., Corda M.G. Dissociation between mesocortical dopamine release and fear-related behaviours in two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions. Eur. J. Neurosci. 17:2003;2716-2726
31. Granon S., Passetti F., Thomas K.L., Dalley J.W., Everitt B.J., Robbins T.W. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J. Neurosci. 20:2000;1208-1215
32. Griebel G., Blanchard D.C., Blanchard R.J. Evidence that the behaviors in the Mouse Defense Test Battery relate to different emotional states: a factor analytic study. Physiol. Behav. 60:1996;1255-1260
33. Griebel G., Blanchard D.C., Jung A., Blanchard R.J. A model of 'antipredator' defense in Swiss-Webster mice: effects of benzodiazepine receptor ligands with different intrinsic activities. Behav. Pharmacol. 6:1995;732-745
34. Griebel G., Blanchard D.C., Jung A., Lee J.C., Masuda C.K., Blanchard R.J. Further evidence that the Mouse Defense Test Battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam. Neuropharmacology. 34:1995;1625-1633
35. Griebel G., Moindrot N., Aliaga C., Simiand J., Soubrie P. Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the Mouse Defense Test Battery. Neurosci. Biobehav. Rev. 25:2001;619-626
36. Griebel G., Perrault G., Sanger D.J. Differences in anxiolytic-like profile of two novel nonbenzodiazepine BZ (omega) receptor agonists on defensive behaviors of mice. Pharmacol. Biochem. Behav. 62:1999;689-694
37. Griebel G., Perrault G., Sanger D.J. Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: evaluation of the importance of intrinsic efficacy and receptor subtype selectivity. Prog. Neuropsychopharmacol. Biol. Psychiatry. 23:1999;81-98
38. Griebel G., Perrault G., Soubrie P. Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents. Psychopharmacology (Berl). 158s:2001;241-251
39. Griebel G., Rodgers R.J., Perrault G., Sanger D.J. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists. Psychopharmacology (Berl). 144:1999;121-130
40. Griebel G., Sanger D.J., Perrault G. The Mouse Defense Test Battery: evaluation of the effects of non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands. Behav. Pharmacol. 7:1996;560-572
41. Gulledge A.T., Jaffe D.B. Multiple effects of dopamine on layer V pyramidal cell excitability in rat prefrontal cortex. J. Neurophysiol. 86:2001;586-595
42. Heidbreder C.A., Weiss I.C., Domeney A.M., Pryce C., Homberg J., Hedou G., et al. Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome. Neuroscience. 100:2000;749-768
43. Heise G.A., Hrabrich B., Lilie N.L., Martin R.A. Scopolamine effects on delayed spatial alternation in the rat. Pharmacol. Biochem. Behav. 3:1975;993-1002
44. Hiramatsu M., Hyodo T., Kameyama T. U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice. Eur. J. Pharmacol. 315:1996;119-125
45. Hiramatsu M., Sasaki M., Nabeshima T., Kameyama T. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice. Pharmacol. Biochem. Behav. 56:1997;73-79
46. Hiramatsu M., Shiotani T., Kameyama T., Nabeshima T. Effects of nefiracetam on amnesia animal models with neuronal dysfunctions. Behav. Brain Res. 83:1997;107-115
47. Ichikawa J., Chung Y.C., Li Z., Dai J., Meltzer H.Y. Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res. 958:2002;176-184
48. Ichikawa J., Meltzer H.Y. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum. J. Pharmacol. Exp. Ther. 291:1999;1227-1232
49. Ihalainen J.A., Riekkinen P. Jr., Feenstra M.G. Comparison of dopamine and noradrenaline release in mouse prefrontal cortex, striatum and hippocampus using microdialysis. Neurosci. Lett. 277:1999;71-74
50. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice. J. Pharmacol. Exp. Ther. 269:1994;15-21
51. Izumi T. Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety. Hokkaido Igaku Zasshi. 73:1998;463-473
52. Kamimura E., Ueno Y., Tanaka S., Sawa H., Yoshioka M., Ueno K.I., et al. New rat model for attention deficit hyperactive disorder (ADHD). Comp. Med. 51:2001;245-251
53. Karler R., Calder L.D., Thai D.K., Bedingfield J.B. The role of dopamine and GABA in the frontal cortex of mice in modulating a motor-stimulant effect of amphetamine and cocaine. Pharmacol. Biochem. Behav. 60:1998;237-244
54. Katz R.J., Chudler R. Y-maze behavior after an analog of ACTH 4 - 9, evidence for an attentional alteration. Psychopharmacology. 71:1980;95-96
55. Kokkinidis L., Anisman H. Dissociation of the effects of scopolamine and D-amphetamine on a spontaneous alternation task. Pharmacol. Biochem. Behav. 5:1976;293-297
56. Kokkinidis L., Anisman H. Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task. Psychopharmacology (Berl). 48:1976;261-270
57. Kokkinidis L., Anisman H. Perseveration and rotational behavior elicited by D-amphetamine in a Y-maze exploratory task: differential effects of intraperitoneal and unilateral intraventricular administration. Psychopharmacology (Berl). 52:1977;123-128
58. Kokkinidis L., Anisman H. Abatement of stimulus perseveration following repeated D-amphetamine treatment: absence of behaviorally augmented tolerance. Pharmacol. Biochem. Behav. 8:1978;557-563
59. Lacroix L., Broersen L.M., Feldon J., Weiner I. Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behav. Brain Res. 107:2000;111-121
60. Lanser M.G., Ellenbroek B.A., Zitman F.G., Heeren D.J., Cools A.R. The role of medial prefrontal cortical dopamine in spontaneous flexibility in the rat. Behav. Pharmacol. 12:2001;163-171
61. Lidow M.S., Koh P.O., Arnsten A.F. D1 dopamine receptors in the mouse prefrontal cortex: Immunocytochemical and cognitive neuropharmacological analyses. Synapse. 47:2003;101-108
62. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185
63. Lorrain D.S., Baccei C.S., Bristow L.J., Anderson J.J., Varney M.A. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience. 117:2003;697-706
64. McFarland D.J. Effects of scopolamine, D-amphetamine, and apomorphine on alternation and position biases. Pharmacol. Biochem. Behav. 32:1989;723-726
65. Miura H., Qiao H., Ohta T. Influence of aging and social isolation on changes in brain monoamine turnover and biosynthesis of rats elicited by novelty stress. Synapse. 46:2002;116-124
66. Morrow B.A., Elsworth J.D., Rasmusson A.M., Roth R.H. The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience. 92:1999;553-564
67. Morrow B.A., Elsworth J.D., Roth R.H. Tyrosine enhances behavioral and mesocorticolimbic dopaminergic responses to aversive conditioning. Synapse. 22:1996;100-105
68. Morrow B.A., Elsworth J.D., Roth R.H. Fear-like biochemical and behavioral responses in rats to the predator odor, TMT, are dependent on the exposure environment. Synapse. 46:2002;11-18
69. Morrow B.A., Lee E.J.K., Taylor J.R., Elsworth J.D., Nye H.E., Roth R.H. (S)-(-)-HA-966, a gamma-hydroxybutyrate-like agent, prevents enhanced mesocorticolimbic dopamine metabolism and behavioral correlates of restraint stress, conditioned fear and cocaine sensitization. J. Pharmacol. Exp. Ther. 283:1997;712-721
70. Morrow B.A., Redmond A.J., Roth R.H., Elsworth J.D. The predator odor, TMT, displays a unique, stress-like pattern of dopaminergic and endocrinological activation in the rat. Brain Res. 864:2000;146-151
71. Morrow B.A., Roth R.H., Elsworth J.D. TMT, a predator odor, elevates mesoprefrontal dopamine metabolic activity and disrupts short-term working memory in the rat. Brain Res. Bull. 52:2000;519-523
72. Murphy B.L., Arnsten A.F., Goldman-Rakic P.S., Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1325-1329
73. Murphy B.L., Arnsten A.F., Jentsch J.D., Roth R.H. Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J. Neurosci. 16:1996;7768-7775
74. Nunes-de-Souza R.L., Canto-de-Souza A., Rodgers R.J. Effects of intra-hippocampal infusion of WAY-100635 on plus-maze behavior in mice. Influence of site of injection and prior test experience. Brain Res. 927:2002;87-96
75. Passetti F., Dalley J.W., Robbins T.W. Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task. Psychopharmacology (Berl). 165:2003;136-145
76. Passetti F., Levita L., Robbins T.W. Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions. Behav. Brain Res. 138:2003;59-69
77. Paxinos G, Franklin KB. The mouse brain in stereotaxic coordinates. 2nd ed. New York: Academic Press; 2001. p. 350.
78. Pehek E.A., McFarlane H.G., Maguschak K., Price B., Pluto C.P. M100, 907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res. 888:2001;51-59
79. Pezze M.A., Bast T., Feldon J. Significance of dopamine transmission in the rat medial prefrontal cortex for conditioned fear. Cereb. Cortex. 13:2003;371-380
80. Ragozzino M.E. The effects of dopamine D(1) receptor blockade in the prelimbic-infralimbic areas on behavioral flexibility. Learn Mem. 9:2002;18-28
81. Raine A., Meloy J.R., Bihrle S., Stoddard J., LaCasse L., Buchsbaum M.S. Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers. Behav. Sci. Law. 16:1998;319-332
82. Rauch S.L., van der Kolk B.A., Fisler R.E., Alpert N.M., Orr S.P., Savage C.R., et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch. Gen Psychiatry. 53:1996;380-387
83. Rodgers R.J., Cao B.J., Dalvi A., Holmes A. Animal models of anxiety: an ethological perspective. Braz. J. Med. Biol. Res. 30:1997;289-304
84. Rodgers R.J., Cole J.C., Aboualfa K., Stephenson L.H. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze. Pharmacol. Biochem. Behav. 52:1995;805-813
85. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci. Biobehav. Rev. 21:1997;801-810
86. Rodgers R.J., Johnson N.J. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52:1995;297-303
87. Rodgers R.J., Johnson N.J., Champion A.J., Mills S. Modulation of plus-maze behaviour in mice by the preferential D3-receptor agonist 7-OH-DPAT. Pharmacol. Biochem. Behav. 54:1996;79-84
88. Rodgers R.J., Nikulina E.M., Cole J.C. Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;985-995
89. Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology. 94:1988;491-495
90. Sorg B.A., Li N., Wu W.R. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization. J. Pharmacol. Exp. Ther. 297:2001;501-508
91. Stanhope K.J., Mirza N.R., Bickerdike M.J., Bright J.L., Harrington N.R., Hesselink M.B., et al. The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. J. Pharmacol. Exp. Ther. 299:2001;782-792
92. Steketee J.D. Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res. Brain Res. Rev. 41:2003;203-228
93. Stevenson C.W., Sullivan R.M., Gratton A. Effects of basolateral amygdala dopamine depletion on the nucleus accumbens and medial prefrontal cortical dopamine responses to stress. Neuroscience. 116:2003;285-293
94. Sullivan R.M., Gratton A. Relationships between stress-induced increases in medial prefrontal cortical dopamine and plasma corticosterone levels in rats: role of cerebral laterality. Neuroscience. 83:1998;81-91
95. Sullivan R.M., Gratton A. Behavioral effects of excitotoxic lesions of ventral medial prefrontal cortex in the rat are hemisphere-dependent. Brain Res. 927:2002;69-79
96. Swonger A.K., Rech R.H. Serotonergic and cholinergic involvement in habituation of activity and spontaneous alternation of rats in a Y maze. J. Comp. Physiol. Psychol. 81:1972;509-522
97. Thiel C.M., Schwarting R.K. Dopaminergic lateralisation in the forebrain: relations to behavioural asymmetries and anxiety in male Wistar rats. Neuropsychobiology. 43:2001;192-199
98. Tidey J.W., Miczek K.A. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res. 721:1996;140-149
99. Trullas R., Skolnick P. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology. 111:1993;323-331
100. Tsuchiya K. Effects of methamphetamine on responsiveness to conditioned fear stress. Hokkaido Igaku Zasshi. 74:1999;41-52
101. Wall P.M., Blanchard R.J., Yang M., Blanchard D.C. Infralimbic D2 receptor influences on anxiety-like behavior and active working memory/attention in CD-1 mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 27:2003;395-410
102. Wall P.M., Flinn J., Messier C. Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice. Psychopharmacology (Berl). 155:2001;58-68
103. Wall P.M., Messier C. Concurrent modulation of anxiety and memory. Behav. Brain Res. 109:2000;229-241
104. Wall P.M., Messier C. Ethological confirmatory factor analysis of anxiety-like behaviour in the murine elevated plus-maze. Behav. Brain Res. 114:2000;199-212
105. Wall P.M., Messier C. U-69, 593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice. Brain Res. 856:2000;259-280
106. Wall P.M., Messier C. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory. Psychopharmacology (Berl). 160:2002;233-244
107. Yoshioka M., Matsumoto M., Togashi H., Saito H. Effect of conditioned fear stress on dopamine release in the rat prefrontal cortex. Neurosci. Lett. 209:1996;201-203
108. Zahrt J., Taylor J.R., Mathew R.G., Arnsten A.F. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J. Neurosci. 17:1997;8528-8535